GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (NAS:BHST) » Definitions » EPS (Diluted)

BHST (BioHarvest Sciences) EPS (Diluted) : $-1.22 (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioHarvest Sciences EPS (Diluted)?

BioHarvest Sciences's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.22.

BioHarvest Sciences's EPS (Basic) for the three months ended in Sep. 2024 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.22.

BioHarvest Sciences's EPS without NRI for the three months ended in Sep. 2024 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.22.

During the past 3 years, the average EPS without NRIGrowth Rate was -14.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, BioHarvest Sciences's highest 3-Year average EPS without NRI Growth Rate was 37.40% per year. The lowest was -80.60% per year. And the median was -14.90% per year.


BioHarvest Sciences EPS (Diluted) Historical Data

The historical data trend for BioHarvest Sciences's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences EPS (Diluted) Chart

BioHarvest Sciences Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.15 -0.70 -0.70 -0.70 -1.05

BioHarvest Sciences Quarterly Data
Oct19 Jan20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -0.70 -0.48 -0.04 -

Competitive Comparison of BioHarvest Sciences's EPS (Diluted)

For the Packaged Foods subindustry, BioHarvest Sciences's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioHarvest Sciences's PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's PE Ratio distribution charts can be found below:

* The bar in red indicates where BioHarvest Sciences's PE Ratio falls into.



BioHarvest Sciences EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

BioHarvest Sciences's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-12.564-0)/13.533
=-0.93

BioHarvest Sciences's Diluted EPS for the quarter that ended in Sep. 2024 is calculated as

Diluted EPS (Q: Sep. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.689-0)/17.3277
=-0.16

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioHarvest Sciences  (NAS:BHST) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


BioHarvest Sciences EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


BioHarvest Sciences Business Description

Traded in Other Exchanges
Address
1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.